Premium
Evaluation of different antimicrobial agents used as selective supplements for isolation and recovery of Yersinia enterocolitica
Author(s) -
Toora S.,
BuduAmoako E.,
Ablett R.F.,
Smith J.
Publication year - 1994
Publication title -
journal of applied bacteriology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.889
H-Index - 156
eISSN - 1365-2672
pISSN - 0021-8847
DOI - 10.1111/j.1365-2672.1994.tb03046.x
Subject(s) - yersinia enterocolitica , morganella morganii , microbiology and biotechnology , antimicrobial , aeromonas hydrophila , aeromonas , bacteria , yersinia , serratia , biology , pseudomonas aeruginosa , isolation (microbiology) , enterobacteriaceae , pseudomonas , escherichia coli , biochemistry , genetics , gene
Seventeen antimicrobial agents were evaluated separately or in combination for their efficiency as selective supplements in a broth medium against six different serotypes of Yersinia enterocolitica and 20 selected strains of different Gram‐negative bacteria. Irgasan (DP300, 5‐chloro‐2‐(2,4‐dichlorophenoxy) phenol) at a concentration of 4 μg ml ‐1 inhibited the growth of most Gram‐negative bacteria with the exceptions of Aeromonas hydrophila, Morganella morganii, Pseudomonas aeruginosa and Serratia liquefaciens. Other antimicrobial agents incorporated in the growth medium, separately or in combination with Irgasan, either inhibited some strains of Y. enterocolitica or did not inhibit the growth of Irgasan‐resistant Gram‐negative bacteria.